Startups

DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.

Summary

Seedtable Score
  • 4
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
Industry

Total funding Amount

$46M

Fundraising History

Investors